1. FRI0215 Comparative efficacy and retention rate of tocilizumab and tnf inhibitors used in combination with methotrexate as first-line biologic therapy in rheumatoid arthritis: data from a multicentre observational registry. (15th June 2017) Authors: Favalli, EG; Biggioggero, M; Puttini, P Sarzi; Atzeni, F; Fusaro, E; Grosso, V; Pellerito, R; Gorla, R; Bazzani, C; Marchesoni, A; Caporali, R Journal: Annals of the rheumatic diseases Issue: Volume 76(2017)Supplement 2 Page Start: 564 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. P018 Anti-carbamylated protein antibodies as a clinical response predictor in rheumatoid arthritis patients treated with abatacept. (March 2019) Authors: Fredi, M; Boldini, M; Kumar, R; Piantoni, S; Cavazzana, I; Garrafa, E; Bazzani, C; Tincani, A; Franceschini, F Journal: Annals of the rheumatic diseases Issue: Volume 78(2019)Supplement 1 Page Start: A6 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. S04.1 Disease activity and clinical remission in systemic lupus erythematosus: comparison between patient and physician perspectives by means of patient reported outcomes (PROS). (27th September 2022) Authors: Fredi, M; Orlandi, C; Salvi, M; Bazzani, C; Nalli, C; Andreoli, L; Franceschini, F Journal: Lupus science & medicine Issue: Volume 9(2022)Supplement 2 Page Start: A5 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗